Cellularline SpA
MIL:CELL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cellularline SpA
MIL:CELL
|
IT |
|
Arcelik AS
F:RCAA
|
TR |
|
M
|
Mitchells & Butlers PLC
DUS:MABB
|
UK |
|
A
|
Amada Co Ltd
XMUN:AA2
|
JP |
|
B
|
BioLine RX Ltd
TASE:BLRX
|
IL |
|
Pharmagest Interactive SA
F:PHF
|
FR |
Wall St Price Targets
CELL Price Targets Summary
Cellularline SpA
According to Wall Street analysts, the average 1-year price target for CELL is 3.98 EUR with a low forecast of 3.94 EUR and a high forecast of 4.1 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CELL's stock price target?
Price Target
3.98
EUR
According to Wall Street analysts, the average 1-year price target for CELL is 3.98 EUR with a low forecast of 3.94 EUR and a high forecast of 4.1 EUR.
What is the Revenue forecast for Cellularline SpA?
Projected CAGR
4%
Over the last 9 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 2 years is 4%.
What is the Operating Income forecast for Cellularline SpA?
Projected CAGR
83%
Over the last 9 years, the compound annual growth rate for Operating Income has been -17%. The projected CAGR for the next 2 years is 83%.
